{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:54:05Z","timestamp":1785556445645,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006256","name":"Universit\u00e0 degli Studi dell'Aquila","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtn.2023.08.020","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:02:03Z","timestamp":1692414123000},"page":"925-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans"],"prefix":"10.1016","volume":"33","author":[{"given":"Antonio","family":"Maurizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Patrizii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-4419","authenticated-orcid":false,"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Maria","family":"Sutera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Baran-Rachwalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttom","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissim","family":"Torabi-Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Dehsorkhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Saffie-Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.08.020_bib1","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2023.08.020_bib2","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group","volume":"102","author":"Wu","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2023.08.020_bib3","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/mtna.2015.21","article-title":"Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.08.020_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2018.02.031","article-title":"RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development","volume":"110","author":"Maurizi","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2023.08.020_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10258","article-title":"Viral vector-based gene therapies in the clinic","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.omtn.2023.08.020_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/M21-2452","article-title":"Association of AZD1222 and BNT162b2 COVID-19 vaccination with thromboembolic and thrombocytopenic events in frontline personnel: A retrospective cohort study","volume":"175","author":"Hviid","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.omtn.2023.08.020_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2013.228","article-title":"Circumventing antivector immunity: potential use of nonhuman adenoviral vectors","volume":"25","author":"Lopez-Gordo","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2023.08.020_bib8","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1002\/1873-3468.13576","article-title":"Adenovirus persistence, reactivation, and clinical management","volume":"593","author":"Lion","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2023.08.020_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2023.08.020_bib10","article-title":"Gene therapy advances: A meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2023.08.020_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omtn.2023.08.020_bib12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/genes13081370","article-title":"Appraisal for the potential of viral and nonviral vectors in gene therapy: A review","volume":"13","author":"Butt","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2023.08.020_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10439-012-0678-1","article-title":"Physical non-viral gene delivery methods for tissue engineering","volume":"41","author":"Mellott","year":"2013","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.omtn.2023.08.020_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fphar.2018.00971","article-title":"Non-viral delivery of nucleic acids: insight into mechanisms of overcoming intracellular barriers","volume":"9","author":"Durymanov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2023.08.020_bib15","first-page":"21","article-title":"Nanotechnology applications for drug delivery","volume":"17","author":"Aston","year":"2005","journal-title":"Pharmaceut. Technol. Eur."},{"key":"10.1016\/j.omtn.2023.08.020_bib16","first-page":"71","article-title":"Nanotechnology approaches to solving the problems of poorly water-soluble drugs","volume":"6","author":"Saffie-Siebert","year":"2005","journal-title":"Drug Discov. World"},{"key":"10.1016\/j.omtn.2023.08.020_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2018.12.080","article-title":"Lipids and polymers in pharmaceutical technology: Lifelong companions","volume":"558","author":"Siepmann","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2023.08.020_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13346-021-00924-7","article-title":"Development of vaccine formulations: past, present, and future","volume":"11","author":"D'Amico","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omtn.2023.08.020_bib19","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.08.020_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2020.07.004","article-title":"Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles","volume":"326","author":"Baran-Rachwalska","year":"2020","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtn.2023.08.020_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"59","author":"Alam","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.omtn.2023.08.020_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46948-5","article-title":"Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ","volume":"9","author":"Hurtado","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.08.020_bib23","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1073\/pnas.0703882104","article-title":"Breaking up the correlation between efficacy and toxicity for nonviral gene delivery","volume":"104","author":"Breunig","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.08.020_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2023.08.020_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2023.08.020_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cbdd.12993","article-title":"Therapeutic potential of chemically modified siRNA: Recent trends","volume":"90","author":"Selvam","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.omtn.2023.08.020_bib27","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.0707831104","article-title":"Sticky overhangs enhance siRNA-mediated gene silencing","volume":"104","author":"Bolcato-Bellemin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.08.020_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41413-019-0055-x","article-title":"Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications","volume":"7","author":"Maurizi","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.omtn.2023.08.020_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2023.08.020_bib30","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: Theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2023.08.020_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11914-020-00587-2","article-title":"Delivery of RNAi-based therapeutics for bone regeneration","volume":"18","author":"Malcolm","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.omtn.2023.08.020_bib32","author":"Saffie-Siebert"},{"key":"10.1016\/j.omtn.2023.08.020_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/46.3.431a","article-title":"Circadian variation in serum CrossLaps concentration is reduced in fasting individuals","volume":"46","author":"Christgau","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtn.2023.08.020_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1364\/JOSAA.1.000612","article-title":"Practical cone-beam algorithm","volume":"1","author":"Feldkamp","year":"1984","journal-title":"J.\u00a0Opt. Soc. Am."},{"key":"10.1016\/j.omtn.2023.08.020_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1145\/37402.37422","article-title":"Marching cubes: a high resolution 3d surface construction algorithm","volume":"21","author":"Lorensen","year":"1987","journal-title":"SIGGRAPH Comput. Graph."},{"key":"10.1016\/j.omtn.2023.08.020_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtn.2023.08.020_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:39:12Z","timestamp":1761874752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":37,"alternative-id":["S2162253123002317"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.08.020","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}